Liang E, Derendorf H
Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville 32610, USA.
J Pharmacokinet Biopharm. 1998 Apr;26(2):247-60. doi: 10.1023/a:1020514024741.
When a pharmacokinetic (PK) two-compartment body model with first-order absorption is fitted to blood levels of a drug, the estimates of the PK parameters may have considerable errors and can cause wrong predictions in other features of the system. The objectives of this report were to illustrate this problem, to provide an easy way to prevent wrong estimation, and to investigate the origin of the mistake. A simple way to prevent wrong interpretation of the calculated PK parameters is to inspect the PK profiles visually. Without observing a clear biphasic profile, one should not apply the two-compartment model if the resulting parameters are to be interpreted and used for further simulations. We investigated the origin of this ambiguity in terms of the relative order of magnitude of microconstants (ka, k12, k21, and k10) and of hybrid constants (A and B). The observed parameter errors will not be of any relevance if the calculated parameters are used only to predict future blood levels over the same time-span. However, if these parameters are used to predict any other characteristic of the system, erroneous predictions may result.
当将具有一级吸收的药代动力学(PK)二室体内模型拟合到药物的血药浓度时,PK参数的估计可能会有相当大的误差,并可能导致对系统其他特征的错误预测。本报告的目的是说明这个问题,提供一种防止错误估计的简便方法,并探究错误的根源。防止对计算出的PK参数进行错误解读的一个简单方法是直观地检查PK曲线。如果没有观察到明显的双相曲线,在解释所得参数并将其用于进一步模拟时,就不应应用二室模型。我们根据微常数(ka、k12、k21和k10)以及混合常数(A和B)的相对数量级研究了这种模糊性的根源。如果仅将计算出的参数用于预测同一时间段内未来的血药浓度,那么观察到的参数误差将无关紧要。然而,如果这些参数用于预测系统的任何其他特征,则可能会导致错误的预测。